283 related articles for article (PubMed ID: 30007458)
1. Bone Marrow Expression of Mast Cell Disorders.
Sánchez-Muñoz L; Henriques AF; Alvarez-Twose I; Matito A
Immunol Allergy Clin North Am; 2018 Aug; 38(3):379-395. PubMed ID: 30007458
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.
Sánchez-Muñoz L; Teodosio C; Morgado JM; Perbellini O; Mayado A; Alvarez-Twose I; Matito A; Jara-Acevedo M; García-Montero AC; Orfao A; Escribano L
Immunol Allergy Clin North Am; 2014 May; 34(2):297-313. PubMed ID: 24745675
[TBL] [Abstract][Full Text] [Related]
3. Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells.
Horny HP; Sotlar K; Valent P
Immunol Allergy Clin North Am; 2014 May; 34(2):315-21. PubMed ID: 24745676
[TBL] [Abstract][Full Text] [Related]
4. New Insights into Clonal Mast Cell Disorders Including Mastocytosis.
Volertas S; Schuler CF; Akin C
Immunol Allergy Clin North Am; 2018 Aug; 38(3):341-350. PubMed ID: 30007455
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.
Sánchez-Muñoz L; Morgado JM; Álvarez-Twose I; Matito A; Garcia-Montero AC; Teodosio C; Jara-Acevedo M; Mayado A; Mollejo M; Caldas C; González de Olano D; Escribano L; Orfao A
Br J Haematol; 2016 Jan; 172(1):56-63. PubMed ID: 26456532
[TBL] [Abstract][Full Text] [Related]
6. Current state of biology and diagnosis of clonal mast cell diseases in adults.
Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L
Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157
[TBL] [Abstract][Full Text] [Related]
7. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
[TBL] [Abstract][Full Text] [Related]
8. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
Taylor ML; Sehgal D; Raffeld M; Obiakor H; Akin C; Mage RG; Metcalfe DD
J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672
[TBL] [Abstract][Full Text] [Related]
9. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
Zheng Y; Nong L; Liang L; Wang W; Li T
Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic criteria and classification of mastocytosis in 2014.
Akin C; Valent P
Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670
[TBL] [Abstract][Full Text] [Related]
11. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
[TBL] [Abstract][Full Text] [Related]
13. Mastocytosis.
Brockow K; Metcalfe DD
Chem Immunol Allergy; 2010; 95():110-124. PubMed ID: 20519885
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.
Akin C
J Mol Diagn; 2006 Sep; 8(4):412-9. PubMed ID: 16931579
[TBL] [Abstract][Full Text] [Related]
15. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
16. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
17. Mastocytosis: from a Molecular Point of View.
Komi DEA; Rambasek T; Wöhrl S
Clin Rev Allergy Immunol; 2018 Jun; 54(3):397-411. PubMed ID: 28725969
[TBL] [Abstract][Full Text] [Related]
18. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
[TBL] [Abstract][Full Text] [Related]
19. Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
Wimazal F; Walchshofer S; Baghestanian M; Chott A; Sperr WR; Kopp C; Sillaber C; Semper H; Horny HP; Tröndle U; Födinger M; Schwarzinger I; Lechner K; Valent P
Wien Klin Wochenschr; 1998 Feb; 110(3):79-88. PubMed ID: 9553202
[TBL] [Abstract][Full Text] [Related]
20. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
